DD201643A5 - Verfahren zur herstellung einer acetylsalicylsaeurehaltigen kapsel - Google Patents

Verfahren zur herstellung einer acetylsalicylsaeurehaltigen kapsel Download PDF

Info

Publication number
DD201643A5
DD201643A5 DD81232634A DD23263481A DD201643A5 DD 201643 A5 DD201643 A5 DD 201643A5 DD 81232634 A DD81232634 A DD 81232634A DD 23263481 A DD23263481 A DD 23263481A DD 201643 A5 DD201643 A5 DD 201643A5
Authority
DD
German Democratic Republic
Prior art keywords
capsule
aspirin
item
alkaline
magnesium
Prior art date
Application number
DD81232634A
Other languages
German (de)
English (en)
Inventor
Tomas M Tencza
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/179,191 external-priority patent/US4294819A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DD201643A5 publication Critical patent/DD201643A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD81232634A 1980-08-18 1981-08-17 Verfahren zur herstellung einer acetylsalicylsaeurehaltigen kapsel DD201643A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/179,191 US4294819A (en) 1980-08-18 1980-08-18 Alkaline analgesic capsule
US06/273,015 US4339428A (en) 1980-08-18 1981-06-18 Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component

Publications (1)

Publication Number Publication Date
DD201643A5 true DD201643A5 (de) 1983-08-03

Family

ID=26875096

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81232634A DD201643A5 (de) 1980-08-18 1981-08-17 Verfahren zur herstellung einer acetylsalicylsaeurehaltigen kapsel

Country Status (25)

Country Link
US (1) US4339428A (es)
AT (1) AT370624B (es)
AU (1) AU549488B2 (es)
CA (1) CA1156554A (es)
CH (1) CH646331A5 (es)
DD (1) DD201643A5 (es)
DE (1) DE3132518A1 (es)
DK (1) DK159374C (es)
ES (1) ES504797A0 (es)
FI (1) FI77371C (es)
FR (1) FR2488508A1 (es)
GB (1) GB2082456B (es)
GR (1) GR74618B (es)
HU (1) HU187354B (es)
IE (1) IE51501B1 (es)
IL (1) IL63577A0 (es)
IT (1) IT1143221B (es)
LU (1) LU83559A1 (es)
NL (1) NL8103804A (es)
NO (1) NO155476C (es)
NZ (1) NZ198045A (es)
OA (1) OA06883A (es)
PT (1) PT73530B (es)
SE (1) SE451667B (es)
ZW (1) ZW19781A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229398A2 (de) * 1986-01-03 1987-07-22 R.P. Scherer GmbH Kapseln sowie Verfahren und Vorrichtung zur Herstellung solcher Kapseln

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
DE3572440D1 (en) * 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
EP0320550A1 (en) * 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
US5071842A (en) * 1988-10-14 1991-12-10 Bristol-Myers Squibb Company Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
AU643703B2 (en) * 1989-09-15 1993-11-25 Cima Labs, Inc. Magnesium carbonate and oil tableting aid
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
US5391230A (en) * 1993-07-07 1995-02-21 Eastman Kodak Company Apparatus for holding solid compact medicaments during processing
EP0778770B1 (en) * 1994-09-02 2003-12-10 Virginia Commonwealth University Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US6511494B1 (en) 2000-11-17 2003-01-28 Embro Corporation Vein harvesting system and method
US6887492B2 (en) * 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
US6576665B2 (en) * 2001-04-03 2003-06-10 Braintree Laboratories, Inc. Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
EP1642593A1 (en) * 2003-06-06 2006-04-05 Takeda Pharmaceutical Company Limited Solid pharmaceutical preparation
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050282756A1 (en) * 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US20060222705A1 (en) * 2005-03-31 2006-10-05 Flanner Henry H Pharmaceutical tablet and apparatus and method for making
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
DE102008025798C5 (de) 2008-05-29 2015-08-06 Guangdong Fushan Glass Machinery Co., Ltd. Verfahren zum Betreiben eines Rollenofens
WO2011008546A2 (en) * 2009-06-29 2011-01-20 Capricorn Pharma, Inc. Solid and semi-solid dosage forms and systems and methods for forming and packaging thereof
CA2784041C (en) 2010-01-05 2017-11-07 Microdose Therapeutx, Inc. Inhalation device and method
US20130143867A1 (en) * 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses
JP2016520653A (ja) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
EP3359131A4 (en) * 2015-10-09 2019-05-01 Combocap, Inc. CAPSULE WITH INTERNAL MEMBRANES FOR IMPROVED BIOVERABILITY

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA593581A (en) * 1960-03-01 W. E. Harrisson Joseph Analgesic product
FR808949A (fr) * 1936-07-31 1937-02-18 Perfectionnements à la préparation des cachets pharmaceutiques
US2224256A (en) * 1938-08-05 1940-12-10 Baker Chem Co J T Pharmaceutical preparation
GB613080A (en) * 1946-05-17 1948-11-22 Myer Coplans Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
US2698332A (en) * 1951-04-20 1954-12-28 Reheis Company Inc Aspirin derivative and method of making
GB754364A (en) * 1953-10-09 1956-08-08 Drug Houses Of Australia Ltd Improvements in medicinal preparations containing acetylsalicylic acid
US2918485A (en) * 1955-09-21 1959-12-22 Keystone Chemurgic Corp Dihydroxy aluminum salicylates
US2889248A (en) * 1955-12-13 1959-06-02 Drug Processors Inc Therapeutic composition containing aluminum proteinate
US2801951A (en) * 1956-01-09 1957-08-06 Sterling Drug Inc Stabilized analgesic compositions
GB827529A (en) * 1956-02-27 1960-02-03 Macleans Ltd Improvements in or relating to the manufacture of tablets
US2888382A (en) * 1957-10-28 1959-05-26 Upjohn Co Therapeutic composition and process
NL245245A (es) * 1958-04-18
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US3323992A (en) * 1960-09-29 1967-06-06 Keystone Chemurgic Corp Antacid composition of hydrated magnesium aluminate containing bound sulfate
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
GB1204580A (en) 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3608064A (en) * 1969-10-07 1971-09-21 Anthony H Lamb Milk-buffered aspirin
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229398A2 (de) * 1986-01-03 1987-07-22 R.P. Scherer GmbH Kapseln sowie Verfahren und Vorrichtung zur Herstellung solcher Kapseln
EP0229398A3 (en) * 1986-01-03 1988-06-22 R.P. Scherer Gmbh Capsules, and method and apparatus for producing such capsules

Also Published As

Publication number Publication date
AT370624B (de) 1983-04-25
CH646331A5 (de) 1984-11-30
FR2488508A1 (fr) 1982-02-19
NO812678L (no) 1982-02-19
NO155476B (no) 1986-12-29
GB2082456B (en) 1984-10-24
DK362781A (da) 1982-02-19
IE51501B1 (en) 1987-01-07
ATA355281A (de) 1982-09-15
SE451667B (sv) 1987-10-26
DE3132518A1 (de) 1982-05-27
GB2082456A (en) 1982-03-10
NO155476C (no) 1987-04-08
GR74618B (es) 1984-06-29
FI77371C (fi) 1989-03-10
SE8104881L (sv) 1982-02-19
CA1156554A (en) 1983-11-08
AU7368281A (en) 1982-02-25
AU549488B2 (en) 1986-01-30
NZ198045A (en) 1985-01-31
US4339428A (en) 1982-07-13
HU187354B (en) 1985-12-28
IL63577A0 (en) 1981-11-30
DK159374B (da) 1990-10-08
PT73530B (en) 1983-10-20
ES8301622A1 (es) 1982-12-16
FI812505L (fi) 1982-02-19
ZW19781A1 (en) 1982-06-16
PT73530A (en) 1981-09-01
IE811881L (en) 1982-02-18
IT8149078A0 (it) 1981-08-10
OA06883A (fr) 1983-04-30
ES504797A0 (es) 1982-12-16
FI77371B (fi) 1988-11-30
NL8103804A (nl) 1982-03-16
DK159374C (da) 1991-07-01
FR2488508B1 (es) 1985-05-10
IT1143221B (it) 1986-10-22
LU83559A1 (fr) 1982-04-14

Similar Documents

Publication Publication Date Title
DD201643A5 (de) Verfahren zur herstellung einer acetylsalicylsaeurehaltigen kapsel
DE69520768T2 (de) Pharmazeutische Zubereitungen, die Fluoxetin enthalten
AU636810B2 (en) Delivery system for enhanced onset and increased potency
DE69821553T2 (de) Granulatzubereitung enthaltend Simethicon und granuliertes wasserfreies Calciumphosphat
DE3780222T2 (de) Pharmazeutische zusammensetzung mit kontrollierter wirkstofffreisetzung.
EP0068191B1 (de) Orale Dipyridamolformen
DE3880762T2 (de) Orale, acetaminophen enthaltende zusammensetzung mit gesteuerter arzneistoff-freisetzung und verfahren zu ihrer herstellung.
DE69732909T2 (de) Rasch zerfallende Pressmasse und Verfahren zu ihrer Herstellung
DE69838300T2 (de) Pharmazeutische suspensionstabletten-zusammenstellungen
DE3879080T2 (de) Pharmazeutische matrix mit verzoegerter freisetzung und verfahren.
DE3887179T2 (de) Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
EP0857064B1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
DE60207383T2 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
US4664915A (en) Compressed and formed alkaline component suitable for use in buffered aspirin product
DE69009175T2 (de) Verwendung eines alkoholfreien Verabreichungssystems für Wirkstoffe, welche oral eingenommen werden.
EP0594570B1 (de) Colestyramin als lipidsenker enthaltende präparate
DE2323686A1 (de) Arzneimittelzubereitungsform mit langzeitwirkung und verfahren zu ihrer herstellung
CA1144861A (en) Alkaline analgesic capsule
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE3237575A1 (de) Neue orale mopidamolformen
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
US5296241A (en) Therapeutic composition and method of using same for treatment of hangover
DE2332484A1 (de) Lutschpastillen mit verzoegerter freigabe
CH630257A5 (en) Sustained release formulation